Bank Pictet & Cie Europe AG Sells 2,742 Shares of Cigna Group $CI

Bank Pictet & Cie Europe AG reduced its holdings in Cigna Group (NYSE:CI) by 19.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,567 shares of the health services provider’s stock after selling 2,742 shares during the period. Bank Pictet & Cie Europe AG’s holdings in Cigna Group were worth $3,334,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CI. Pathway Financial Advisers LLC grew its stake in shares of Cigna Group by 2.3% in the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after acquiring an additional 34 shares during the last quarter. Armstrong Advisory Group Inc. boosted its holdings in Cigna Group by 17.7% in the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after purchasing an additional 34 shares during the period. Central Pacific Bank Trust Division grew its position in Cigna Group by 1.0% in the 2nd quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider’s stock worth $1,137,000 after purchasing an additional 35 shares during the last quarter. HM Payson & Co. increased its holdings in shares of Cigna Group by 0.9% during the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after purchasing an additional 35 shares during the period. Finally, Carr Financial Group Corp raised its position in shares of Cigna Group by 5.3% during the third quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock valued at $204,000 after buying an additional 36 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Cantor Fitzgerald decreased their target price on Cigna Group from $365.00 to $325.00 in a research report on Friday, October 31st. Raymond James Financial reiterated a “strong-buy” rating on shares of Cigna Group in a research report on Monday, November 3rd. Wolfe Research decreased their price objective on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, October 15th. Jefferies Financial Group restated a “buy” rating and issued a $310.00 target price on shares of Cigna Group in a research note on Monday, November 3rd. Finally, Truist Financial reduced their target price on Cigna Group from $375.00 to $310.00 in a research report on Friday, October 31st. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $331.83.

Cigna Group Price Performance

Cigna Group stock opened at $275.06 on Friday. The business has a 50 day simple moving average of $272.75 and a 200 day simple moving average of $290.49. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76. The company has a market capitalization of $73.48 billion, a PE ratio of 12.13, a price-to-earnings-growth ratio of 1.00 and a beta of 0.26. Cigna Group has a one year low of $239.51 and a one year high of $350.00.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the prior year, the company posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, sell-side analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Investors of record on Thursday, December 4th were issued a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is currently 26.64%.

Insider Buying and Selling

In other news, CEO David Cordani purchased 4,134 shares of Cigna Group stock in a transaction on Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the transaction, the chief executive officer directly owned 157,935 shares in the company, valued at approximately $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is currently owned by company insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.